James Q. Oeswein
13Patents
11h-index
15Co-inventors
65Inventor score
Filing activity: Apr 15, 1988 → May 6, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6171586A | Antibody formulation | Chemistry; Metallurgy | 611 | Expired |
| US5096885A | Human growth hormone formulation | Human Necessities | 90 | Expired |
| US5472022A | Injection pen solution transfer apparatus and method | Human Necessities | 88 | Expired |
| US5374620A | Growth-promoting composition and its use | Emerging Cross-Sectional Technologies | 88 | Expired |
| US5783556A | Formulated insulin-containing composition | Human Necessities | 52 | Expired |
| US6991790B1 | Antibody formulation | Chemistry; Metallurgy | 47 | Expired |
| US5763394A | Human growth hormone aqueous formulation | Human Necessities | 35 | Expired |
| US6448225B2 | Human growth hormone aqueous formulation | Human Necessities | 34 | Expired |
| US5981485A | Human growth hormone aqueous formulation | Human Necessities | 30 | Expired |
| US6559122B1 | Formulated composition | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5681814A | Formulated IGF-I Composition | Human Necessities | 19 | Expired |
| US5597802A | Method of formulating IGF-I with growth hormone | Human Necessities | 6 | Expired |
| US7186686B2 | Formulated composition | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.